Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Hemann, Michael T."'
Autor:
Dalin S; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Grauman-Boss B; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Lauffenburger DA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. lauffen@mit.edu.; Department of Biological Engineering, Massachusetts Institute of Technology, Room: 16-343, Cambridge, MA, 02139, USA. lauffen@mit.edu., Hemann MT; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. hemann@mit.edu.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. hemann@mit.edu.
Publikováno v:
Scientific reports [Sci Rep] 2022 Mar 31; Vol. 12 (1), pp. 5453. Date of Electronic Publication: 2022 Mar 31.
Autor:
Bent EH; The David H. Koch Institute for Integrative Cancer Research, Cambridge, MA, 02142, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Millán-Barea LR; The David H. Koch Institute for Integrative Cancer Research, Cambridge, MA, 02142, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Zhuang I; The David H. Koch Institute for Integrative Cancer Research, Cambridge, MA, 02142, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Goulet DR; The David H. Koch Institute for Integrative Cancer Research, Cambridge, MA, 02142, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Fröse J; The David H. Koch Institute for Integrative Cancer Research, Cambridge, MA, 02142, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA., Hemann MT; The David H. Koch Institute for Integrative Cancer Research, Cambridge, MA, 02142, USA. hemann@mit.edu.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142, USA. hemann@mit.edu.
Publikováno v:
Nature communications [Nat Commun] 2021 Oct 28; Vol. 12 (1), pp. 6218. Date of Electronic Publication: 2021 Oct 28.
Autor:
Mueller HS; The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139., Fowler CE; The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139., Dalin S; The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139., Moiso E; The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139., Udomlumleart T; The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139., Garg S; The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114., Hemann MT; The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139., Lees JA; The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; jalees@mit.edu.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Aug 24; Vol. 118 (34).
Autor:
Roux B; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Vaganay C; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Vargas JD; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Benaksas C; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Pardieu B; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Fenouille N; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Ellegast JM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Malolepsza E; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Ling F; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Sodaro G; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France., Ross L; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Tang Y; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Wu T; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Anderson DJ; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Le Moigne R; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Zhou HJ; Cleave Therapeutics Inc., San Francisco, CA 94105, USA., Luciano F; IRCAN, INSERM U1081 and CNRS UMR 7284, 06189 Nice, France., Hartigan CR; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Galinsky I; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA., Auberger P; C3M, INSERM U1065, Team Cell Death, Differentiation, Inflammation and Cancer, 06204 Nice, France., Schenone M; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Carr SA; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Guirouilh-Barbat J; Université de Paris, INSERM U1016 and CNRS UMR 8104, Institut Cochin, 75014 Paris, France., Lopez B; Université de Paris, INSERM U1016 and CNRS UMR 8104, Institut Cochin, 75014 Paris, France., Khaled M; INSERM U1186, Gustave-Roussy Cancer Center, Université Paris-Saclay, 94805 Villejuif, France., Lage K; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Hermine O; Université de Paris, INSERM U1163 and CNRS 8254, Institut Imagine, Hôpital Necker, APHP, 75015 Paris, France., Hemann MT; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Puissant A; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France. lina.benajiba@inserm.fr kimberly_stegmaier@dfci.harvard.edu alexandre.puissant@inserm.fr., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, MA 02215, USA. lina.benajiba@inserm.fr kimberly_stegmaier@dfci.harvard.edu alexandre.puissant@inserm.fr.; Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, MA 02142, USA., Benajiba L; Université de Paris, INSERM U944 and CNRS UMR 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, 75010 Paris, France. lina.benajiba@inserm.fr kimberly_stegmaier@dfci.harvard.edu alexandre.puissant@inserm.fr.
Publikováno v:
Science translational medicine [Sci Transl Med] 2021 Mar 31; Vol. 13 (587).
Autor:
Bruno PM; Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA 02115.; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115.; Department of Genetics, Harvard Medical School, Boston, MA 02115., Lu M; Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802., Dennis KA; Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802., Inam H; Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802., Moore CJ; Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802., Sheehe J; Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802., Elledge SJ; Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA 02115; selledge@genetics.med.harvard.edu hemann@mit.edu jrp94@psu.edu.; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115.; Department of Genetics, Harvard Medical School, Boston, MA 02115., Hemann MT; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142; selledge@genetics.med.harvard.edu hemann@mit.edu jrp94@psu.edu., Pritchard JR; Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802; selledge@genetics.med.harvard.edu hemann@mit.edu jrp94@psu.edu.; Huck Institute for the Life Sciences, The Pennsylvania State University, University Park, PA 16802.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Feb 25; Vol. 117 (8), pp. 4053-4060. Date of Electronic Publication: 2020 Feb 10.
Publikováno v:
Nature [Nature] 2019 Aug; Vol. 572 (7769), pp. 321-322.
Autor:
Wojtaszek JL; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA., Chatterjee N; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Najeeb J; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA., Ramos A; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Lee M; Department of Chemistry, Duke University, Durham, NC 27708, USA., Bian K; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA., Xue JY; Trinity College of Arts & Sciences, Duke University, Durham, NC 27708, USA., Fenton BA; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA., Park H; Department of Chemistry, Duke University, Durham, NC 27708, USA., Li D; Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA., Hemann MT; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: hemann@mit.edu., Hong J; Department of Chemistry, Duke University, Durham, NC 27708, USA; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: jiyong.hong@duke.edu., Walker GC; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: gwalker@mit.edu., Zhou P; Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: peizhou@biochem.duke.edu.
Publikováno v:
Cell [Cell] 2019 Jun 27; Vol. 178 (1), pp. 152-159.e11. Date of Electronic Publication: 2019 Jun 06.
Autor:
Yamanaka K; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America., Chatterjee N; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America., Hemann MT; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.; Koch Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America., Walker GC; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Publikováno v:
PLoS genetics [PLoS Genet] 2017 Aug 17; Vol. 13 (8), pp. e1006842. Date of Electronic Publication: 2017 Aug 17 (Print Publication: 2017).
Autor:
Flamme M; Department of Chemistry, King's College London, London, SE1 1DB, UK., Cressey PB; Department of Chemistry, King's College London, London, SE1 1DB, UK., Lu C; Department of Chemistry, King's College London, London, SE1 1DB, UK., Bruno PM; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, USA., Eskandari A; Department of Chemistry, King's College London, London, SE1 1DB, UK., Hemann MT; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, USA., Hogarth G; Department of Chemistry, King's College London, London, SE1 1DB, UK., Suntharalingam K; Department of Chemistry, King's College London, London, SE1 1DB, UK.
Publikováno v:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2017 Jul 18; Vol. 23 (40), pp. 9674-9682. Date of Electronic Publication: 2017 Jun 27.
Autor:
Bruno PM; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Liu Y; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Park GY; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Murai J; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA., Koch CE; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Eisen TJ; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Howard Hughes Medical Institute, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA., Pritchard JR; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Pommier Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA., Lippard SJ; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Hemann MT; The Koch Institute for Integrative Cancer Research at MIT, Cambridge, Massachusetts, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Publikováno v:
Nature medicine [Nat Med] 2017 Apr; Vol. 23 (4), pp. 461-471. Date of Electronic Publication: 2017 Feb 27.